These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30368009)

  • 1. Hypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome.
    Shamriz O; Patel K; Marsh RA; Bleesing J; Joshi AY; Lucas L; Prince C; Pencheva BB; Kobrynski L; Chandrakasan S
    Clin Immunol; 2018 Dec; 197():219-223. PubMed ID: 30368009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation.
    Bacchetta R; Barzaghi F; Roncarolo MG
    Ann N Y Acad Sci; 2018 Apr; 1417(1):5-22. PubMed ID: 26918796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A challenging undertaking: Stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
    Kucuk ZY; Bleesing JJ; Marsh R; Zhang K; Davies S; Filipovich AH
    J Allergy Clin Immunol; 2016 Mar; 137(3):953-5.e4. PubMed ID: 26559324
    [No Abstract]   [Full Text] [Related]  

  • 4. Lentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX Syndrome.
    Masiuk KE; Laborada J; Roncarolo MG; Hollis RP; Kohn DB
    Cell Stem Cell; 2019 Feb; 24(2):309-317.e7. PubMed ID: 30639036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey.
    Bekis Bozkurt H; Bayram Catak F; Sahin A; Yalcin Gungoren E; Gemici Karaarslan B; Yakici N; Yorgun Altunbas M; Catak MC; Can S; Amirov R; Bozkurt S; Ozturk N; Bilgic Eltan S; Kasap N; Bal Cetinkaya F; Orhan F; Arga M; Cavkaytar O; Kiykim A; Karakoc-Aydiner E; Ozen A; Baris S
    J Clin Immunol; 2024 Sep; 45(1):9. PubMed ID: 39283523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome with very early onset inflammatory bowel disease-like changes].
    Bao WT; Li ZL; Li J; Shi XY; Zhang J; Wu H
    Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):559-561. PubMed ID: 31269558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature.
    Chen CA; Chung WC; Chiou YY; Yang YJ; Lin YC; Ochs HD; Shieh CC
    J Microbiol Immunol Infect; 2016 Oct; 49(5):775-782. PubMed ID: 26748735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients.
    Passerini L; Barzaghi F; Curto R; Sartirana C; Barera G; Tucci F; Albarello L; Mariani A; Testoni PA; Bazzigaluppi E; Bosi E; Lampasona V; Neth O; Zama D; Hoenig M; Schulz A; Seidel MG; Rabbone I; Olek S; Roncarolo MG; Cicalese MP; Aiuti A; Bacchetta R
    J Allergy Clin Immunol; 2020 Apr; 145(4):1262-1271.e13. PubMed ID: 31874182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.
    Barzaghi F; Amaya Hernandez LC; Neven B; Ricci S; Kucuk ZY; Bleesing JJ; Nademi Z; Slatter MA; Ulloa ER; Shcherbina A; Roppelt A; Worth A; Silva J; Aiuti A; Murguia-Favela L; Speckmann C; Carneiro-Sampaio M; Fernandes JF; Baris S; Ozen A; Karakoc-Aydiner E; Kiykim A; Schulz A; Steinmann S; Notarangelo LD; Gambineri E; Lionetti P; Shearer WT; Forbes LR; Martinez C; Moshous D; Blanche S; Fisher A; Ruemmele FM; Tissandier C; Ouachee-Chardin M; Rieux-Laucat F; Cavazzana M; Qasim W; Lucarelli B; Albert MH; Kobayashi I; Alonso L; Diaz De Heredia C; Kanegane H; Lawitschka A; Seo JJ; Gonzalez-Vicent M; Diaz MA; Goyal RK; Sauer MG; Yesilipek A; Kim M; Yilmaz-Demirdag Y; Bhatia M; Khlevner J; Richmond Padilla EJ; Martino S; Montin D; Neth O; Molinos-Quintana A; Valverde-Fernandez J; Broides A; Pinsk V; Ballauf A; Haerynck F; Bordon V; Dhooge C; Garcia-Lloret ML; Bredius RG; Kałwak K; Haddad E; Seidel MG; Duckers G; Pai SY; Dvorak CC; Ehl S; Locatelli F; Goldman F; Gennery AR; Cowan MJ; Roncarolo MG; Bacchetta R;
    J Allergy Clin Immunol; 2018 Mar; 141(3):1036-1049.e5. PubMed ID: 29241729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10.
    Liu JQ; Jabbari A; Lin CH; Akkanapally V; Frankel WL; Basu S; He K; Zheng P; Liu Y; Bai XF
    J Immunol; 2024 Sep; 213(5):559-566. PubMed ID: 38975727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.
    Verbsky JW; Chatila TA
    Curr Opin Pediatr; 2013 Dec; 25(6):708-14. PubMed ID: 24240290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-voltage-Gated Potassium Channel (VGKC) Antibodies and Acquired Neuromyotonia in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy X-Lined (IPEX) Syndrome.
    Moseley N; King J; Van Dort B; Williams S; Rodriguez-Casero V; Ramachandran S; Choo S; Cole T; McLean-Tooke A
    J Clin Immunol; 2021 Nov; 41(8):1972-1974. PubMed ID: 34478044
    [No Abstract]   [Full Text] [Related]  

  • 13. Unusual and early onset IPEX syndrome: a case report.
    Doğruel D; Gürbüz F; Turan İ; Altıntaş DU; Yılmaz M; Yüksel B
    Turk J Pediatr; 2019; 61(4):580-584. PubMed ID: 31990476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Polyendocrine Syndromes.
    Husebye ES; Anderson MS; Kämpe O
    N Engl J Med; 2018 Mar; 378(12):1132-1141. PubMed ID: 29562162
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular feature and therapeutic perspectives of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
    Huang Q; Liu X; Zhang Y; Huang J; Li D; Li B
    J Genet Genomics; 2020 Jan; 47(1):17-26. PubMed ID: 32081609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome.
    Colobran R; Álvarez de la Campa E; Soler-Palacín P; Martín-Nalda A; Pujol-Borrell R; de la Cruz X; Martínez-Gallo M
    Clin Immunol; 2016 Feb; 163():60-5. PubMed ID: 26748374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome.
    Yamauchi T; Takasawa K; Kamiya T; Kirino S; Gau M; Inoue K; Hoshino A; Kashimada K; Kanegane H; Morio T
    Pediatr Diabetes; 2019 Nov; 20(7):1035-1040. PubMed ID: 31322807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extremely Early Onset IPEX Syndrome Caused by a Novel Small Exonic Deletion in FOXP3.
    Smith E; Greeley SA; Ye H; Torgerson TR; Dimmitt R; Atkinson P; Philips J; Goldman F
    J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):e119-e120. PubMed ID: 25187107
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonclassic Inflammatory Bowel Disease in Young Infants: Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome, and Other Disorders.
    Chandrakasan S; Venkateswaran S; Kugathasan S
    Pediatr Clin North Am; 2017 Feb; 64(1):139-160. PubMed ID: 27894441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IPEX Syndrome: Genetics and Treatment Options.
    Ben-Skowronek I
    Genes (Basel); 2021 Feb; 12(3):. PubMed ID: 33668198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.